EGFR-TKI (unspecified)

epidermal growth factor receptor tyrosine kinase inhibitor

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EGFR-TKI (unspecified), covering 2025-01-27 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1